Clinical Trials
24 trialsNCT04751396 2026-05-20
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
Recruiting
NCT06641089 2026-05-18
IZAR-2
MoonLake Immunotherapeutics AG
Phase 3 Recruiting
NCT03816345 2026-05-13
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT04936308 2026-05-08
SOLSTICE
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT02450396 2026-03-27
EGR2
Assistance Publique - Hôpitaux de Paris
Withdrawn
NCT04806620 2026-01-22
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
Recruiting
NCT05413044 2025-12-08
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
Bristol-Myers Squibb
Completed
NCT05421442 2025-12-08
DANBIO
Bristol-Myers Squibb
Completed
NCT03284879 2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
NCT03796858 2025-02-03
COSMOS
Janssen Pharmaceutica N.V., Belgium
Phase 3 Completed
NCT01797224 2025-01-28
OTIS Cimzia Pregnancy Registry
University of California, San Diego
Active not recruiting
NCT02775500 2025-01-28
Apremilast Pregnancy Exposure Registry
University of California, San Diego
Active not recruiting
NCT04731831 2024-06-28
Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.
Aalborg University Hospital
Recruiting
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT03840928 2023-12-13
PatientSpot Formerly Known as ArthritisPower
Global Healthy Living Foundation
Unknown
NCT02538341 2021-11-23
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
University of Alabama at Birmingham
Phase 2 Completed
NCT02627768 2021-06-21
PsaBio
Janssen Pharmaceutica N.V., Belgium
Completed
NCT03162796 2021-02-03
Discover-1
Janssen Research & Development, LLC
Phase 3 Completed
NCT03456206 2020-11-10
PROCID-DCH
University of Southern Denmark
Unknown
NCT01060098 2020-01-18
T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
Imperial College London
Completed
NCT03330769 2019-04-17
UPSTREAM
University of Cagliari
Unknown
NCT02028169 2017-04-27
To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)
AbbVie
Completed
NCT01519089 2015-08-13
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
Pfizer
Phase 3 Completed
NCT00432406 2009-03-11
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
Chinese University of Hong Kong
Phase 4 Completed